Inhibition of anti-CD3 and interleukin-2 stimulated T lymphocyte proliferation by peptidomimetic opioid compound

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 2, 2003, Pages 225-233

  Narayan, P ^a   Pandey, R ^a   Yadav, V S ^a   Tandon, R ^b   Haq, W ^b   Dhar, M M ^b   Singh, V K ^a,c  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Anti CD3; Immunomodulator; MAPkinase; Peptidomimetic compound

Indexed keywords

AUTOANTIBODY; CD3 ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE;

ANIMAL CELL; ARTICLE; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL DIVISION; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OPIOID PEPTIDES; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

ANIMALIA;

EID: 0037570739     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120020472     Document Type: Article

References (25)

1. Wybran, J.; Appelboom, T.; Famaey, J.P.; Govaerts, A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 1979, 123, 1068-1070.
2. Hollt, V. Opioid peptide processing and receptor selectivity. Annu. Rev. Pharmacol. Toxicol. 1986, 26, 59-77.
3. Gilman, S.C.; Schwartz, J.M.; Milner, R.J.; Bloom, F.E.; Feldlman, J.D. β-endorphin enhances lymphocyte proliferative responses. Proc. Natl Acad. Sci. USA 1982, 79, 4226-4230.
4. Plotnikoff, N.P. The Ying-Yang hypothesis of opioid peptide immunomodulation. Pshychopharmacol. Bull. 1985, 21, 489.
5. Singh, V.K.; Bajpai, K.; Biswas, S.; Haq, W.; Khan, M.Y.; Mathur, K.B. Molecular biology of opioid receptors: recent advances. Neuroimmunomodulation 1997, 4, 285-297.
6. Mazumder, S.; Nath, I.; Dhar, M.M. Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol. Lett. 1993, 35, 33-38.
7. Singh, V.K.; Bajpai, K.; Biswas, S.; Mathur, K.B.; Haq, W.; Agarwal, S.S. Met-enkephalin and its analogs as immunomodulators. Anim. Biol. 1998, 7, 45-58.
8. Bajpai, K.; Singh, V.K.; Agarwal, S.S.; Dhawan, V.C.; Naqvi, T.; Haq, W.; Mathur, K.B. Immunomodulatory activity of met-enkephalin and its two potent analogs. Int. J. Immunopharmacol. 1995, 17, 207-212.
9. Bajpai, K.; Singh, V.K.; Dhawan, V.C.; Haq, W.; Mathur, K.B.; Agarwal, S.S. Immunomodulation by two potent analogs of met-enkephalin. Immunopharmacology 1997, 35, 213-220.
10. Singh, V.K.; Bajpai, K.; Narayan, P.; Yadav, V.S.; Dhawan, V.C.; Haq, W.; Mathur, K.B.; Agarwal, S.S. δ-opioid receptor antagonist inhibits immunomodulation by met-enkephalin analogs. Neuroimmunomodulation 1999, 6, 355-360.
11. Gorin, F.A.; Balasubramanium, T.M.; Cicero, T.J.; Schwietzer, J.; Marshall, G.R. Novel analogues of enkephalin: identification of functional groups required for biological activity. J. Med. Chem. 1980, 23, 1113-1122.
12. Morley, J.S. Chemistry of opioid peptides. Br. Med. Bull. 1983, 39, 5-10.
13. Morley, J.S. Structure-activity relationship of enkephalin like peptides. Annu. Rev. Pharmacol. Toxicol. 1980, 20, 81-110.
14. Roques, B.P.; Fournie-Zaluski, M.C.; Gacel, G.; David, M.; Meunier, J.C.; Maigret, B.; Morgan, J.L. Rational design and biological properties of highly specific μ and δ-opioid peptides. Adv. Biochem. Psychopharmacol. 1982, 33, 321-331.
15. Dhar, M.M. Enkephalins and Immunomodulation. Ind. J. Chem. 1991, 30B, 278-280.
16. Narayan, P.; Singh, V.K.; Agarwal, S.S.; Tandon, R.; Haq, W.; Raghubir, R.; Dhar, M.M. Immunomodulation by opioid peptidomimetic compound. Neuroimmunomodulation 2001, 9, 134-140.
17. Narayan, P.; Tandon, R.; Haq, W.; Dhar, M.M.; Singh, V.K. Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound. Int. Immunopharmacol. 2002, 2, 751-757.
18. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein dye binding. Ann. Biochem. 1976, 72, 248-254.
19. Heagy, W.; Teng, E.; Lopez, P.; Finberg, R.W. Enkephalin receptor and receptor-mediated signal transduction in cultured human lymphocytes. Cell. Immunol. 1999, 191, 34-48.
20. Kowalski, J. Immunomodulatory action of class μ, δ and κ-opioid receptor agonists in mice. Neuropeptides 1998, 32, 301-306.
21. Wright, S.D.; Romas, R.A.; Tobias, P.S.; Ulevitch, R.J.; Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide and LPS-binding protein. Science 1990, 249, 1431-1433.
22. Stefanova, I.; Corcoran, M.L.; Horak, E.M.; Wahl, L.M.; Bolen, J.B.; Horak, I.D. Lipopolysaccharide induces activation of CD14 associated protein tyrosine kinase p53/p56lyn. J. Biol. Chem. 1993, 268, 20725-20728.
23. Paul, A.; Pendreigh, R.H.; Plevin, R. Protein kinase C and tyrosine kinase pathways regulates lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages. Br. J. Pharmacol. 1995, 114, 482-488.
24. Su, B.; Karin, M. Mitogen activated protein kinase cascade and regulation of gene expression. Curr. Opin. Immunol. 1996, 8, 402-411.
25. Lahti, A.; Lahde, M.; Kankaanranta, H.; Moilanen, E. Inhibition of extracellular regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. J. Pharmacol. Exp. Ther. 2000, 294, 1188-1194.